Neurotrope, Inc. Common
NTRP
NTRP was delisted on the 1st of December, 2020.
23 hedge funds and large institutions have $5.07M invested in Neurotrope, Inc. Common in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.
117% more call options, than puts
Call options by funds: $311K | Put options by funds: $143K
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
15% less funds holding
Funds holding: 27 → 23 (-4)
44% less capital invested
Capital invested by funds: $9M → $5.07M (-$3.93M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
+$157K |
| 2 |
CC
Cannell & Co
New York
|
+$136K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$88.8K |
| 4 |
CD
Carl Domino
West Palm Beach,
Florida
|
+$76.4K |
| 5 |
VF
Virtu Financial
New York
|
+$65.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIM
Spark Investment Management
New York
|
-$214K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$105K |
| 3 |
Wolverine Trading
Chicago,
Illinois
|
-$70.2K |
| 4 |
Morgan Stanley
New York
|
-$55K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$21K |
NTRP Hedge Fund Activity: Q3 2017 in Review
23 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Neurotrope, Inc. Common (NTRP) for Q3 2017, worth a combined $5.07M — down 44% from $9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NTRP and 3 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was JP Morgan Private Wealth Advisors, adding an estimated $157K. The largest seller was Spark Investment Management, exiting entirely with an estimated $214K sold.
- 23 institutional investors held Neurotrope, Inc. Common (NTRP) as of Q3 2017, down from 27 in Q2 2017.
- Funds reported $5.07M of Neurotrope, Inc. Common stock for Q3 2017, down 44% quarter-over-quarter.
- 3 funds opened new Neurotrope, Inc. Common positions in Q3 2017 and 6 closed out, a net change of -3 holders.
- The largest Neurotrope, Inc. Common buyer in Q3 2017 was JP Morgan Private Wealth Advisors, an estimated $157K added.
- The largest Neurotrope, Inc. Common seller in Q3 2017 was Spark Investment Management, an estimated $214K sold.
Based on aggregated 13F filings for Q3 2017.